Skip to main content
. 2021 Aug 23:1–9. doi: 10.1017/S0007114521003214

Table 5.

Association of E-DII with inflammatory and clinical markers in patient with COVID-19 (n 60)

Variable Model 1 Model 2§ Model 3||
B 95 % CI P * B 95 % CI P * B 95 % CI P *
CRP (mg/dl) 1·37 0·72, 2·02 < 0·001 1·38 0·69, 2·08 < 0·001 1·40 0·61, 2·22 < 0·001
ESR (mm/h) 1·41 0·52, 2·30 0·002 1·25 0·30, 2·21 0·011 1·02 0·19, 1·98 0·018
Hospital time (d) 0·17 –0·04, 0·39 0·112 0·13 –0·10, 0·05 0·264 0·13 –0·05, 0·31 0·155
ICU time (d) 0·006 –0·14, 0·15 0·931 –0·02 –0·18, 0·14 0·784 –0·06 –0·20, 0·12 0·562
Severity 0·04 0·01, 0·07 0·005 0·03 0·01, 0·06 0·020 0·03 0·01, 0·06 0·024
BDI 2·35 1·25, 5·50 < 0·001 1·30 0·85, 3·21 0·015 1·10 0·50, 2·50 0·025

E-DII, Energy-Adjusted Dietary Inflammatory Index; CRP, C-reactive protein; ESR, erythrocyte sedimentation rate; ICU, intensive care unit; BDI: Beck Depression Inventory.

*

P based on linear regression.

Analysis limited to case group.

Unadjusted.

§

Adjusted for age and sex.

||

Adjusted for Model 1 + BMI, diabetes and blood pressure.

Severity of disease were assessed by chest radiology criteria.